Join The Fight
Donation protected
Giving Californian firefighters and first responders the medical surveillance they deserve!
California is being hit by wildfires like never before and the forecast for the next years looks grim. Thousands of brave women and men are risking everything to protect residents’ lives and family homes. The health effects of repeated, intense wildfire exposure are largely unknown but evidence in the 9/11 aftermath, increasingly shows that the consequences of exposure to particulate matter are quite severe.
We at FiGHT feel strongly that firefighters deserve state-of-the-art medical surveillance. We started working with clinical centers and organization across the state to establish a program to screen firefighters - free of charge - for lung diseases. Early detection is the key to better treatment outcomes and a sustained healthy life.
While working through the arduous process of reimbursement, we are launching a crowdfunding charity initiative to give the firefighters the medical surveillance they deserve right now! The funds raised will be used for setting up a large scale research initiative implementing state-of-the-art medical technology to screen firefighters. Data collected will provide valuable insights and a better understanding of the effects of wildfire exposure and smoke inhalation with the aim of detecting diseases early on and developing more effective treatment options.
Fluidda is the world leader in the field of imaging in pulmonology, by means of the development of their Functional Respiratory Imaging technology, which combines aerospace engineering (computational fluid dynamics) and biomedical imaging techniques. Fluidda's proprietary FRI technology offers healthcare providers regional insights into the lungs of patients with any lung disorder. With applications in both clinical practice and drug development, FRI is set to become a new standard tool in pulmonology. Recently FRI has been combined with artificial intelligence algorithms, with incredible sensitivity in both early-stage disease detection and prediction of disease progression. These developments enable to start an overall earlier and more patient-specific treatment, allowing for better clinical outcomes. Recently, Fluidda has been mentioned in Nature and Forbes , for revolutionizing respiratory care.
Please find more info regarding project goals on jointhefight.info
California is being hit by wildfires like never before and the forecast for the next years looks grim. Thousands of brave women and men are risking everything to protect residents’ lives and family homes. The health effects of repeated, intense wildfire exposure are largely unknown but evidence in the 9/11 aftermath, increasingly shows that the consequences of exposure to particulate matter are quite severe.
We at FiGHT feel strongly that firefighters deserve state-of-the-art medical surveillance. We started working with clinical centers and organization across the state to establish a program to screen firefighters - free of charge - for lung diseases. Early detection is the key to better treatment outcomes and a sustained healthy life.
While working through the arduous process of reimbursement, we are launching a crowdfunding charity initiative to give the firefighters the medical surveillance they deserve right now! The funds raised will be used for setting up a large scale research initiative implementing state-of-the-art medical technology to screen firefighters. Data collected will provide valuable insights and a better understanding of the effects of wildfire exposure and smoke inhalation with the aim of detecting diseases early on and developing more effective treatment options.
Fluidda is the world leader in the field of imaging in pulmonology, by means of the development of their Functional Respiratory Imaging technology, which combines aerospace engineering (computational fluid dynamics) and biomedical imaging techniques. Fluidda's proprietary FRI technology offers healthcare providers regional insights into the lungs of patients with any lung disorder. With applications in both clinical practice and drug development, FRI is set to become a new standard tool in pulmonology. Recently FRI has been combined with artificial intelligence algorithms, with incredible sensitivity in both early-stage disease detection and prediction of disease progression. These developments enable to start an overall earlier and more patient-specific treatment, allowing for better clinical outcomes. Recently, Fluidda has been mentioned in Nature and Forbes , for revolutionizing respiratory care.
Please find more info regarding project goals on jointhefight.info
Organizer
Team Join The Fight
Organizer
Los Angeles, CA